CNR1 anticorps (AA 161-187)
Aperçu rapide pour CNR1 anticorps (AA 161-187) (ABIN1881140)
Antigène
Voir toutes CNR1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 161-187
-
Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogène
- This CB1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 161-187 amino acids of human CB1.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB: 1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Date de péremption
- 6 months
-
-
-
: "Widespread decrease of type 1 cannabinoid receptor availability in Huntington disease in vivo." dans: Journal of nuclear medicine : official publication, Society of Nuclear Medicine, Vol. 51, Issue 9, pp. 1413-7, (2010) (PubMed).
: "Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain." dans: Journal of clinical psychopharmacology, Vol. 30, Issue 4, pp. 441-5, (2010) (PubMed).
: "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." dans: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, (2010) (PubMed).
: "Expression of cannabinoid receptors in human kidney." dans: Histology and histopathology, Vol. 25, Issue 9, pp. 1133-8, (2010) (PubMed).
-
: "Widespread decrease of type 1 cannabinoid receptor availability in Huntington disease in vivo." dans: Journal of nuclear medicine : official publication, Society of Nuclear Medicine, Vol. 51, Issue 9, pp. 1413-7, (2010) (PubMed).
-
- CNR1 (Cannabinoid Receptor 1 (CNR1))
-
Autre désignation
- CB1
-
Sujet
- This gene encodes one of two cannabinoid receptors. The cannabinoids, principally delta-9-tetrahydrocannabinol and synthetic analogs, are psychoactive ingredients of marijuana. The cannabinoid receptors are members of the guanine-nucleotide-binding protein (G-protein) coupled receptor family, which inhibit adenylate cyclase activity in a dose-dependent, stereoselective and pertussis toxin-sensitive manner. The two receptors have been found to be involved in the cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana. Multiple transcript variants encoding two different protein isoforms have been described for this gene. [provided by RefSeq].
-
Poids moléculaire
- 52858
-
NCBI Accession
- NP_001153698, NP_001153730, NP_001153731, NP_057167, NP_149421
-
UniProt
- P21554
-
Pathways
- Feeding Behaviour
Antigène
-